Skip to main navigation Skip to search Skip to main content

Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAR) is associated with the risk of splanchnic vein thrombosis

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)181-185
Number of pages5
JournalThrombosis and Haemostasis
Volume97
Issue number2
DOIs
Publication statusPublished - 2007

Research programs

  • EMC MM-04-20-02-A

Cite this